The Mediterranean Diet (MeDiet), a healthy, plant-based dietary pattern, is
recommended by international scientific organizations for its potential in
cardiovascular disease (CVD) prevention.1 However, its underlying mechanisms
remain incompletely understood.2 Increased carotid intimamedia
thickness (CIMT), plaque height and inflammation are recognized
as indicators of cardiovascular risk.3,4 Results of previous studies indicate
that following the MeDiet may slow CIMT and carotid plaque progression5
and improve vascular inflammation.6 However, to our knowledge, no published
studies have assessed whether changes in inflammatory biomarkers
resulting from long-term MeDiet intervention correlate with changes in
CIMT and plaque height. We hypothesize that MeDiet’s beneficial impact
on atherosclerosis—through improving CIMT and plaque height—
correlates with its immunomodulatory effects on inflammation and plaque
stability-related molecule